TNON (Tenon Medical) ROCE %: -203.39% (As of Mar. 2026)


TNON Tenon Medical Inc TNON
38 GF Score
Price $0.29
GF Value $0.35
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Tenon Medical ROCE %?

Tenon Medical TNON -10.39% 38 ROCE % is -203.39% as of Mar. 2026. GuruFocus rates TNON with a GF Score™ of 38/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Tenon Medical's annualized ROCE % for the quarter that ended in Mar. 2026 was -203.39%.

Tenon Medical  (NAS:TNON) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Tenon Medical ROCE % Related Terms

Tenon Medical ROCE % Historical Data

* Premium members only.

The historical data trend for Tenon Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenon Medical ROCE % Chart

Tenon Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 0.00 -1,451.94 -264.54 -244.01 -161.79

Tenon Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -150.88 -112.16 -168.25 -152.34 -203.39
TNON
38GF Score
Tenon Medical Inc TNON
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenon Medical ROCE % Calculation

Tenon Medical's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-12.556/( ( (9.843 - 1.869) + (10.76 - 3.213) )/ 2 )
=-12.556/( (7.974+7.547)/ 2 )
=-12.556/7.7605
=-161.79 %

Tenon Medical's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-13.2/( ( (10.76 - 3.213) + (12.838 - 7.405) )/ 2 )
=-13.2/( ( 7.547 + 5.433 )/ 2 )
=-13.2/6.49
=-203.39 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -203.39% mean?
Tenon Medical (TNON) has a ROCE % of -203.39% as of Mar. 2026.
Is Tenon Medical's ROCE % too high?
Tenon Medical's current ROCE % is -203.39%. Overall, Tenon Medical has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's ROCE % compare to XAIR and VVOS?
Tenon Medical's ROCE % of -203.39% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenon Medical's current ROCE % is -203.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current ROCE % is -203.39%. Tenon Medical's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Tenon Medical (TNON), the current ROCE % is -203.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tenon Medical (TNON) Overvalued in 2026?

Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued. The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35. GuruFocus considers Tenon Medical to be Modestly Undervalued.

Key valuation signals for TNON:

  • ROCE %: -203.39%
  • GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tenon Medical Business Description

Address 104 Cooper Court, Los Gatos, CA, USA, 95032
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
38GF Score

Get the complete analysis for TNON

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price
$0.35
GF Value